##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

Published Jan 31, 2025

Arno Hennig  

Abstract

Multiple sclerosis (MS) is a complicated, multifaceted autoimmune disorder marked by damage to the myelin sheath of the central nervous system. The precise etiology of MS remains incompletely elucidated, though it is thought to arise from an interplay of genetic and environmental influences. Genetic predisposition contributes to the likelihood of acquiring MS, particularly in persons with a familial history of the illness. Moreover, environmental factors such as viral infections, vitamin D insufficiency, smoking, specific dietary practices, and exercise lacking have been associated with the initiation of an aberrant immune response that results in inflammation and demyelination within the central nervous system. Researchers persist in examining the complex underpinnings of MS to formulate more effective treatments and interventions for individuals impacted by this chronic neurological disorder.

##plugins.themes.bootstrap3.article.details##

Keywords

Multiple Sclerosis, Etiology, Genetics, Environmental Factors, Progression

Supporting Agencies

No funding source declared.

References
Ascherio, A. (2013). Environmental factors in multiple sclerosis. Expert Review of Neurotherapeutics, 13(sup2), 3–9. DOI: https://doi.org/10.1586/14737175.2013.865866

Barrie, W., Yang, Y., Irving-Pease, E. K., Attfield, K. E., Scorrano, G., Jensen, L. T., Armen, A. P., Dimopoulos, E. A., Stern, A., Refoyo-Martinez, A., Pearson, A., Ramsøe, A., Gaunitz, C., Demeter, F., Jørkov, M. L. S., Møller, S. B., Springborg, B., Klassen, L., Hyldgård, I. M., . . . Willerslev, E. (2024). Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations. Nature, 625(7994), 321–328. DOI: https://doi.org/10.1038/s41586-023-06618-z

Bishop, E. L., Ismailova, A., Dimeloe, S., Hewison, M., & White, J. H. (2020). Vitamin D and immune regulation: Antibacterial, Antiviral, Anti‐Inflammatory. JBMR Plus, 5(1). DOI: https://doi.org/10.1002/jbm4.10405

Cai, L., & Huang, J. (2018). Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study. Neuropsychiatric Disease and Treatment, Volume 14, 2241–2254. DOI: https://doi.org/10.2147/ndt.s173280

Cekanaviciute, E., Yoo, B. B., Runia, T. F., Debelius, J. W., Singh, S., Nelson, C. A., Kanner, R., Bencosme, Y., Lee, Y. K., Hauser, S. L., Crabtree-Hartman, E., Sand, I. K., Gacias, M., Zhu, Y., Casaccia, P., Cree, B. a. C., Knight, R., Mazmanian, S. K., & Baranzini, S. E. (2017). Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proceedings of the National Academy of Sciences, 114(40), 10713–10718. DOI: https://doi.org/10.1073/pnas.1711235114

Chen, J., Chia, N., Kalari, K. R., Yao, J. Z., Novotna, M., Soldan, M. M. P., Luckey, D. H., Marietta, E. V., Jeraldo, P. R., Chen, X., Weinshenker, B. G., Rodriguez, M., Kantarci, O. H., Nelson, H., Murray, J. A., & Mangalam, A. K. (2016). Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Scientific Reports, 6(1). DOI: https://doi.org/10.1038/srep28484
Compston, A., & Coles, A. (2008). Multiple sclerosis. The Lancet, 372(9648), 1502–1517. DOI: https://doi.org/10.1016/s0140-6736(08)61620-7

Correale, J., Marrodan, M., & Ysrraelit, M. C. (2019). Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis. Biomedicines, 7(1), 14. DOI: https://doi.org/10.3390/biomedicines7010014

Dargahi, N., Katsara, M., Tselios, T., Androutsou, M., De Courten, M., Matsoukas, J., & Apostolopoulos, V. (2017). Multiple sclerosis: Immunopathology and treatment update. Brain Sciences, 7(7), 78. DOI: https://doi.org/10.3390/brainsci7070078

DeLorenze, G. N., Munger, K. L., Lennette, E. T., Orentreich, N., Vogelman, J. H., & Ascherio, A. (2006). Epstein-Barr virus and multiple sclerosis. Archives of Neurology, 63(6), 839. DOI: https://doi.org/10.1001/archneur.63.6.noc50328

Didonna, A., & Oksenberg, J. R. (2015). Genetic determinants of risk and progression in multiple sclerosis. Clinica Chimica Acta, 449, 16–22. DOI: https://doi.org/10.1016/j.cca.2015.01.034

Didonna, A., & Oksenberg, J. R. (2017). The genetics of multiple sclerosis. In Codon Publications eBooks (pp. 3–16). DOI: https://doi.org/10.15586/codon.multiplesclerosis.2017.ch1

Eva, L., Pleș, H., Covache-Busuioc, R., Glavan, L. A., Bratu, B., Bordeianu, A., Dumitrascu, D., Corlatescu, A. D., & Ciurea, A. V. (2023). A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments. Biomedicines, 11(9), 2489. DOI: https://doi.org/10.3390/biomedicines11092489

Fernandez, A. M., Papais-Alvarenga, M., Fernandez, V., Guerrero, M., & Fernandez, O. (2011). Microbes, immunity and multiple sclerosis. Current Immunology Reviews, 7(1), 75–82. DOI: https://doi.org/10.2174/157339511794474262

Goldberg, P. (1974a). Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence. International Journal of Environmental Studies, 6(1), 19–27. DOI: https://doi.org/10.1080/00207237408709630

Goldberg, P. (1974b). Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence. International Journal of Environmental Studies, 6(1), 19–27. DOI: https://doi.org/10.1080/00207237408709630

Gourraud, P., Harbo, H. F., Hauser, S. L., & Baranzini, S. E. (2012). The genetics of multiple sclerosis: an up-to-date review. Immunological Reviews, 248(1), 87-103. DOI: https://doi.org/10.1111/j.1600-065x.2012.01134.x

Haahr, S., & Höllsberg, P. (2006). Multiple sclerosis is linked to Epstein-Barr virus infection. Reviews in Medical Virology, 16(5), 297–310. DOI: https://doi.org/10.1002/rmv.503

Hadgkiss, E. J., Jelinek, G. A., Weiland, T. J., Pereira, N. G., Marck, C. H., & Van Der Meer, D. M. (2014). The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutritional Neuroscience, 18(3), 125–136. DOI: https://doi.org/10.1179/1476830514y.0000000117

Harris, V. K., & Sadiq, S. A. (2014). Biomarkers of Therapeutic Response in Multiple sclerosis: current status. Molecular Diagnosis & Therapy, 18(6), 605–617. DOI: https://doi.org/10.1007/s40291-014-0117-0

Hayes, C. E., & Acheson, E. D. (2008). A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10. Medical Hypotheses, 71(1), 85–90. DOI: https://doi.org/10.1016/j.mehy.2008.01.031

Hemmer, B., Cepok, S., Zhou, D., & Sommer, N. (2004). Multiple sclerosis - a coordinated immune attack across the blood brain barrier. Current Neurovascular Research, 1(2), 141–150. DOI: https://doi.org/10.2174/1567202043480152

Høglund, R. A., & Maghazachi, A. (2014). Multiple sclerosis and the role of immune cells. World Journal of Experimental Medicine, 4(3), 27. DOI: https://doi.org/10.5493/wjem.v4.i3.27

Ifergan, I., & Miller, S. D. (2020). Potential for targeting myeloid cells in controlling CNS inflammation. Frontiers in Immunology, 11. DOI: https://doi.org/10.3389/fimmu.2020.571897

Jakimovski, D., Guan, Y., Ramanathan, M., Weinstock-Guttman, B., & Zivadinov, R. (2019). Lifestyle-based modifiable risk factors in multiple sclerosis: Review of experimental and clinical findings. Neurodegenerative Disease Management, 9(3), 149–172. DOI: https://doi.org/10.2217/nmt-2018-0046

Jangi, S., Gandhi, R., Cox, L. M., Li, N., Von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., Cook, S., Tankou, S., Stuart, F., Melo, K., Nejad, P., Smith, K., Topçuolu, B. D., Holden, J., Kivisäkk, P., . . . Weiner, H. L. (2016). Alterations of the human gut microbiome in multiple sclerosis. Nature Communications, 7(1). DOI: https://doi.org/10.1038/ncomms12015

Janssen, F., Braun, M., Dröge, J., Brüggmann, D., & Groneberg, D. A. (2024). Comparison between smoked tobacco and medical cannabis cigarettes concerning particulate matter. Cannabis and Cannabinoid Research. DOI: https://doi.org/10.1089/can.2023.0201

Joy, J. E., & Johnston, R. B., Jr. (2001). Characteristics and management of major symptoms. Multiple Sclerosis - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK222388/

Khan, F., Amatya, B., & Turner-Stokes, L. (2011). Symptomatic therapy and rehabilitation in primary progressive multiple sclerosis. Neurology Research International, 2011, 1–22. DOI: https://doi.org/10.1155/2011/740505

Koch, M. W., Metz, L. M., Agrawal, S. M., & Yong, V. W. (2012). Environmental factors and their regulation of immunity in multiple sclerosis. Journal of the Neurological Sciences, 324(1–2), 10–16. DOI: https://doi.org/10.1016/j.jns.2012.10.021

Laurence, M., & Benito-León, J. (2017). Epstein–Barr virus and multiple sclerosis: Updating Pender’s hypothesis. Multiple Sclerosis and Related Disorders, 16, 8–14. DOI: https://doi.org/10.1016/j.msard.2017.05.009

Libbey, J. E., Cusick, M. F., & Fujinami, R. S. (2013). Role of pathogens in multiple sclerosis. International Reviews of Immunology, 33(4), 266–283. DOI: https://doi.org/10.3109/08830185.2013.823422

Macleod, G. (2016). Understanding multiple sclerosis by examination of theories in medical literature. MOJ Cell Science & Report, 3(5). DOI: https://doi.org/10.15406/mojcsr.2016.03.00072

Mandia, D., Ferraro, O., Nosari, G., Montomoli, C., Zardini, E., & Bergamaschi, R. (2014). Environmental Factors and multiple sclerosis severity: A Descriptive study. International Journal of Environmental Research and Public Health, 11(6), 6417–6432. DOI: https://doi.org/10.3390/ijerph110606417

Martin, R., McFarland, H. F., & McFarlin, D. E. (1992). Immunological aspects of demyelinating diseases. Annual Review of Immunology, 10(1), 153–187. DOI: https://doi.org/10.1146/annurev.iy.10.040192.001101

Mazzucca, C. B., Scotti, L., Comi, C., Vecchio, D., Chiocchetti, A., & Cappellano, G. (2024). The role of diet in multiple sclerosis onset: A prospective study using UK Biobank. Nutrients, 16(11), 1746. DOI: https://doi.org/10.3390/nu16111746

Munger, K. L., & Ascherio, A. (2007). Risk factors in the development of multiple sclerosis. Expert Review of Clinical Immunology, 3(5), 739–748. DOI: https://doi.org/10.1586/1744666x.3.5.739

Nishanth, K., Tariq, E., Nzvere, F. P., Miqdad, M., & Cancarevic, I. (2020). Role of smoking in the pathogenesis of multiple sclerosis: a review article. Cureus. DOI: https://doi.org/10.7759/cureus.9564

Nouh, R. A., Kamal, A., Oyewole, O., Abbas, W. A., Abib, B., Omar, A., Mansour, S. T., & Abdelnaser, A. (2024). Unveiling the potential of cannabinoids in multiple sclerosis and the dawn of Nano-Cannabinoid medicine. Pharmaceutics, 16(2), 241. DOI: https://doi.org/10.3390/pharmaceutics16020241

Ochoa-Repáraz, J., Kirby, T. O., & Kasper, L. H. (2018). The gut microbiome and multiple sclerosis. Cold Spring Harbor Perspectives in Medicine, 8(6), a029017. DOI: https://doi.org/10.1101/cshperspect.a029017

Ortiz, G. G., Pacheco-Moisés, F. P., Bitzer-Quintero, O. K., Ramírez-Anguiano, A. C., Flores-Alvarado, L. J., Ramírez-Ramírez, V., Macias-Islas, M. A., & Torres-Sánchez, E. D. (2013). Immunology and oxidative stress in multiple sclerosis: Clinical and Basic approach. Clinical and Developmental Immunology, 2013, 1–14. DOI: https://doi.org/10.1155/2013/708659

Otaequi, D., Muñoz-Culla, N., & Irizar, N. (2013). The genetics of multiple sclerosis: review of current and emerging candidates. The Application of Clinical Genetics, 63. DOI: https://doi.org/10.2147/tacg.s29107

Pierrot-Deseilligny, C. (2009). Clinical implications of a possible role of vitamin D in multiple sclerosis. Journal of Neurology, 256(9), 1468–1479. DOI: https://doi.org/10.1007/s00415-009-5139-x

Pierrot-Deseilligny, C., & Souberbielle, J. (2017). Vitamin D and multiple sclerosis: An update. Multiple Sclerosis and Related Disorders, 14, 35–45. DOI: https://doi.org/10.1016/j.msard.2017.03.014

Pytel, V., Matías‐Guiu, J. A., Torre‐Fuentes, L., Montero, P., Gómez‐Graña, Á., García‐Ramos, R., Moreno‐Ramos, T., Oreja‐Guevara, C., Fernández‐Arquero, M., Gómez‐Pinedo, U., & Matías‐Guiu, J. (2017). Familial multiple sclerosis and association with other autoimmune diseases. Brain and Behavior, 8(1). DOI: https://doi.org/10.1002/brb3.899

Rolak, L. A. (2003). Multiple sclerosis: it’s not the disease you thought it was. Clinical Medicine & Research, 1(1), 57–60. DOI: https://doi.org/10.3121/cmr.1.1.57

Roos, J. (2017). Combination aquatic and land physical therapy program improved function and reduced spasticity after acute illness and exacerbation of multiple sclerosis: A case report. Physical Medicine and Rehabilitation Research, 1(4). DOI: https://doi.org/10.15761/pmrr.1000118

Schepici, G., Silvestro, S., Bramanti, P., & Mazzon, E. (2019). The gut microbiota in multiple sclerosis: An overview of clinical trials. Cell Transplantation, 28(12), 1507–1527. DOI: https://doi.org/10.1177/0963689719873890

Shahi, S. K., Freedman, S. N., & Mangalam, A. K. (2017). Gut microbiome in multiple sclerosis: The players involved and the roles they play. Gut Microbes, 8(6), 607–615. DOI: https://doi.org/10.1080/19490976.2017.1349041

Smolders, J., Damoiseaux, J., Menheere, P., & Hupperts, R. (2008). Vitamin D as an immune modulator in multiple sclerosis, a review. Journal of Neuroimmunology, 194(1–2), 7–17. DOI: https://doi.org/10.1016/j.jneuroim.2007.11.014

Stoiloudis, P., Kesidou, E., Bakirtzis, C., Sintila, S., Konstantinidou, N., Boziki, M., & Grigoriadis, N. (2022). The Role of Diet and Interventions on Multiple Sclerosis: A review. Nutrients, 14(6), 1150. DOI: https://doi.org/10.3390/nu14061150
Tsutsui, S., & Stys, P. K. (2012). Metabolic injury to axons and myelin. Experimental Neurology, 246, 26–34. DOI: https://doi.org/10.1016/j.expneurol.2012.04.016

Virtanen, J. O., & Jacobson, S. (2012). Viruses and multiple sclerosis. CNS & Neurological Disorders - Drug Targets, 11(5), 528–544. DOI: https://doi.org/10.2174/187152712801661220

Waldman, A., Ghezzi, A., Bar-Or, A., Mikaeloff, Y., Tardieu, M., & Banwell, B. (2014). Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research. The Lancet Neurology, 13(9), 936–948. DOI: https://doi.org/10.1016/s1474-4422(14)70093-6

Weinshenker, B. G. (1994). Natural history of multiple sclerosis. Annals of Neurology, 36(S1), S6–S11. DOI: https://doi.org/10.1002/ana.410360704

Weston, M., & Constantinescu, C. S. (2015). What role does tobacco smoking play in multiple sclerosis disability and mortality? A review of the evidence. Neurodegenerative Disease Management, 5(1), 19–25. DOI: https://doi.org/10.2217/nmt.14.45

Zivadinov, R. (2015). Role of neuroimaging in multiple sclerosis. In Elsevier eBooks (pp. 443–478). DOI: https://doi.org/10.1016/b978-0-12-800763-1.00018-x
How to Cite
Hennig, A. (2025). Multiple Sclerosis: Where Does It Exactly Stem From?. Science Insights, 46(1), 1705–1710. https://doi.org/10.15354/si.25.pe195
Section
Perspective